Literature DB >> 12595195

Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease.

Petra Ruprecht-Dörfler1, Daniela Berg, Oliver Tucha, Peter Benz, Michael Meier-Meitinger, Gesine L Alders, Klaus W Lange, Georg Becker.   

Abstract

Increased echogenicity of the substantia nigra (SN) on ultrasound is a typical sonographic finding in Parkinson's disease (PD). Sonographic signal intensity of the SN is related to tissue iron content with higher iron level being associated with increased echogenicity. Recent findings indicate that hyperechogenicity of the SN represents an important susceptibility factor for nigrostriatal degeneration. In this study we determined the prevalence of a characteristic ultrasound sign of Parkinson's disease in first-degree relatives of PD patients. Fourteen patients with sporadic PD and 58 of their relatives underwent neurological, neuropsychological, and ultrasound examination. In addition, four pairs of relatives (one member of each pair exhibiting increased echogenicity of the SN and the other with regular SN echogenicity) underwent (18)F-Dopa PET examination. On transcranial sonography, 26 of the 58 relatives exhibited SN hyperechogenicity. Twenty-four relatives showed minor signs of motor slowing. Relatives with SN hyperechogenicity more often showed signs of hypokinesia (16 v 8 relatives; U test, P = 0.01) and impaired executive functions (Tower of London task, problems solved with the minimum number of moves; U test, P = 0.012) than relatives without this echo pattern. In addition, (18)F-Dopa uptake (influx constants) at the putamen was reduced in subjects with SN hyperechogenicity compared to their relatives without this ultrasound sign (Wilcoxon, P = 0.03). In conclusion, approximately 45% of relatives of PD patients exhibited an increased echogenicity of the SN. This sign is associated with clinical findings and objective measurements, indicating some degree of impaired nigrostriatal function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12595195     DOI: 10.1016/s1053-8119(02)00035-6

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  25 in total

Review 1.  Neuroimaging in Parkinson's disease.

Authors:  A Jon Stoessl
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Premotor Parkinson's disease: concepts and definitions.

Authors:  Andrew Siderowf; Anthony E Lang
Journal:  Mov Disord       Date:  2012-04-15       Impact factor: 10.338

Review 3.  Early diagnosis of Parkinson's disease.

Authors:  Jörg Spiegel; Alexander Storch; Wolfgang H Jost
Journal:  J Neurol       Date:  2006-08       Impact factor: 4.849

4.  Substantia nigra hyperechogenicity with LRRK2 G2019S mutations.

Authors:  Norbert Brüggemann; Johann Hagenah; Kaili Stanley; Christine Klein; Cuiling Wang; Deborah Raymond; Laurie Ozelius; Susan Bressman; Rachel Saunders-Pullman
Journal:  Mov Disord       Date:  2011-02-10       Impact factor: 10.338

5.  Clinical characteristics related to worsening of motor function assessed by the Unified Parkinson's Disease Rating Scale in the elderly population.

Authors:  Inga Liepelt-Scarfone; Stefanie Lerche; Stefanie Behnke; Jana Godau; Alexandra Gaenslen; Christoph Pausch; Klaus Fassbender; Kathrin Brockmann; Karin Srulijes; Heiko Huber; Isabel Wurster; Daniela Berg
Journal:  J Neurol       Date:  2014-12-02       Impact factor: 4.849

Review 6.  Developments in the role of transcranial sonography for the differential diagnosis of parkinsonism.

Authors:  Andrea Pilotto; Rezzak Yilmaz; Daniela Berg
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

Review 7.  Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies.

Authors:  Adriane Gröger; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2012-08-09       Impact factor: 3.575

8.  Transcranial sonography of the substantia nigra: digital image analysis.

Authors:  D Skoloudík; M Jelínková; J Blahuta; P Cermák; T Soukup; P Bártová; K Langová; R Herzig
Journal:  AJNR Am J Neuroradiol       Date:  2014-07-24       Impact factor: 3.825

Review 9.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.

Authors:  Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2011-01-05       Impact factor: 3.575

10.  Transcranial sonography for diagnosis of Parkinson's disease.

Authors:  Sabine Mehnert; Iris Reuter; Karsten Schepp; Peter Maaser; Erwin Stolz; Manfred Kaps
Journal:  BMC Neurol       Date:  2010-01-21       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.